Interventional Neurology Market by Product Type (Neurothrombectomy Devices), Disease Pathology (Cerebral Aneurysms), Technique (Coiling), End-Use (Ambulatory care centers), and Region (Asia Pacific, Europe, North America, Middle East, and Africa, Latin America), and forecast period-2022 – 2030 (Updated Version Available)

Interventional Neurology Market Insights:

Interventional neurology market was valued at USD 2.46 Billion in 2021, registering a CAGR of 5.4% during the forecast period (2022-2030), and the market is projected to be worth USD 3.85 Billion by 2030. Interventional neurology is a catheter-based, endovascular approach for diagnosis and treatment of nervous system disorders such as subdural hemorrhage, subarachnoid hemorrhage and extradural hemorrhage, Parkinson disease, epilepsy and others. The digital subtraction angiography image scan of blood arteries in the brain is utilized for diagnosis of abnormalities in blood flow. 

Interventional neurology devices aid in the diagnosis, treatment, and prevention of multiple neurological conditions such as Alzheimer’s, major depressive disorder, spinal cord injury, Parkinson’s disease, epilepsy, and traumatic brain injury. For instance, as per the reports from World Health Organization, an estimation of over 15 million people globally suffer from strokes each year. Thus, the increased prevalence of strokes among the population is projected to contribute the largest share to the growth of the interventional neurology market. Additionally, product reimbursements by major companies are anticipated to lead the market growth. For instance, in June 2021, MicroVention Europe and Terumo France/Europe received reimbursement for the RoadsaverTM carotid stent system owing to the positive assessment from French National Authority for Health (HAS). Further, In 2021, North America is expected to contribute the largest market share due to the availability of advanced medical treatment devices, rising investments in medical infrastructure, and higher purchasing power. Thus, the above-mentioned factors are estimated to support the growth of the interventional neurology market during the forecast period.

Interventional Neurology Market Dynamics:

Interventional neurology is a subspecialty within the neurological branch of the medical industry. Interventional neurology comprises radiography and catheter employment to diagnose and treat multiple central nervous system conditions and diseases like brain aneurysms through minimally invasive neurosurgery methods such as embolectomy, coil embolization, stenting, and others.

Driver:

The major driver of the interventional neurology market is rising investments in research and development in the biotechnology and pharmaceutical industry owing to the need for alternative therapeutics for reduced risks of neurovascular diseases among patients. Moreover, the increased patient pool suffering from cerebral aneurysms, strokes, and other neurovascular disorders, the rising introduction of technologically advanced medical devices, and growing investments in healthcare facilities are major factors fostering the growth of the interventional neurology market.

Restraint:

The expensive neurovascular surgeries combined with the higher cost of medical devices and instruments used in surgical interventions are expected to obstruct the growth of the interventional neurology market. Additionally, the poor reimbursement structure, especially in developing countries such as Mexico, India, and Brazil, in terms of neurological treatment and unsupportive government reforms are anticipated to hinder market growth.

Opportunity:

The rising awareness among people about the treatment of neurovascular diseases and increased demand for minimally invasive medical interventions due to quick patient recovery, reduced hospital stay, higher procedural safety & efficacy, and greater affordability are expected to generate profitable opportunities for market growth. Furthermore, the increased prevalence of neurovascular diseases among the geriatric population combined with the growing acceptance of endoscopic surgical procedures are expected to offer lucrative opportunities for the growth of the interventional neurology market.

COVID-19 Analysis of the Interventional Neurology Market:

The interventional neurology market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. The factors such as poor supply chain, reduced number of patient visits, decreased rate of interventional radiology (IR) procedures, and economic slowdown are the major impacts of COVID-19 that hampered the growth of the interventional neurology market. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a medical devices manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the interventional neurology market is moderate. Post covid-19 there was a positive impact on the interventional neurology market as consumers were more focused on neurovascular disease treatment.

Interventional Neurology Report Coverage:

Report Attributes	Report Details
Study Timeline	2016-2030
Market Size in 2030 (USD Billion)	3.85  Billion
CAGR (2022-2030)	5.4%
By Product Type	Aneurysm Coiling Devices and Cerebral Embolization (Embolic coils, Flow diversion devices, Liquid embolic agents), Neurothrombectomy Devices, Cerebral Angioplasty and Stenting Systems, Support devices
By Disease Pathology	Arteriovenous Malformation and Fistulas,  Cerebral Aneurysms, Ischemic Strokes, and Others (cavernous malformations and Moyamoya disease)
By Technique	Neurothrombectomy Procedure, Cerebral Angiography Technique, Carotid Endarterectomy (CEA), Stenting, Microsurgical Clipping, Coiling, Flow Diversion, and Others
By End-Use	Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes
By Geography	North America– (U.S., Canada, Mexico) Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, and Rest of MEA)
Key Players	Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Terumo Corporation, Penumbra Inc., Microport Scientific Corporation, Merit Medical Systems Inc., W.L. Gore & Associates Inc., B. Braun

Interventional Neurology Market Segment Analysis:

By Product Type

The product type segment is divided into cerebral angioplasty and stenting systems, support devices, aneurysm coiling devices, cerebral embolization, and neurothrombectomy devices. The aneurysm coiling devices and cerebral embolization is further sub-segmented into liquid embolic agents, flow diversion devices, and embolic coils. In 2021, the aneurysm coiling devices and cerebral embolization segment is projected to contribute the largest share to the growth of the interventional neurology market due to the growing preference for minimally invasive neurosurgical interventions and the growing availability of embolic coils for neurovascular treatments.  Additionally, the features such as the reduced risk of coil relapse in the main artery, proximal control of the aneurysm rupture, and low procedural mortality rates are anticipated to support the growth of aneurysm coiling devices and cerebral embolization segment during the forecast period.

By Disease Pathology

The disease pathology segment is separated into cerebral aneurysms, arteriovenous malformation, and fistulas, ischemic strokes, others (Moyamoya disease and cavernous malformations). In 2021, the cerebral aneurysms segment is expected to contribute the largest share to the growth of the interventional neurology market owing to the increasing preference for minimally invasive neurosurgical procedures among neurosurgeons which result in reduced risks of infections and faster recovery times in patients. Additionally, the rising expenditures in healthcare facilities and growing incidences of risk factors such as cigarette smoking, high blood pressure, diabetes, high cholesterol, and obesity are also expected to support the growth of the interventional neurology market.

By Technique

Based on technique, the segment is categorized into neurothrombectomy procedure, cerebral angiography technique, carotid endarterectomy (CEA), stenting, microsurgical clipping, coiling, flow diversion, and others. The neurothrombectomy procedure is anticipated to grow with the largest CAGR during the forecast period. The factors such as increased usage of minimally invasive surgical treatment of ischemic stroke and reduced risks of clotting are estimated to support the growth of the neurothrombectomy procedure segment. Furthermore, the cerebral angiography technique segment is also projected to contribute to the growth of the interventional neurology market. The factors such as the reduced need for surgical intervention decreased rate of side effects caused by the radiation, and precise imaging of blood vessels in the brain are expected to support the growth of the cerebral angiography technique segment in the projected period.

By End-Use

The end-user segment is divided into ambulatory care centers, hospitals & surgical centers, and research laboratories & academic institutes. The hospitals & surgical centers segment held the leading share in the interventional neurology market. The large availability of neurosurgeons combined with access to advanced medical devices and instruments are the major factors that are expected to augment the growth of the hospitals & surgical centers segment during the projected period. Furthermore, the ambulatory care centers segment is also anticipated to grow with the fastest CAGR in 2021. The factors such as the increased accessibility of ambulatory care centers especially in developing countries such as India, Brazil, Mexico, and others, the ease of treatment scheduling, and rising expenditure on efficacy and safety of such centers are expected to accelerate the growth of the ambulatory care centers segment in the forecast period.

By Region

The regional segment includes Asia Pacific, Europe, North America, the Middle East, and Africa, Latin America. In 2021, North America contributed the largest share to the growth of the interventional neurology market due to the rising burden of neurodegenerative diseases like Parkinson’s disease, Alzheimer’s, and others. Additionally, the presence of leading market players, increased expenditure in manufacturing of neurology devices and favorable government regulations boost are projected to support the growth of the interventional neurology market in the North American region.

The Asia Pacific is also expected to dominate the growth of the interventional neurology market during the forecast period. The factors such as increased development of healthcare infrastructures, rise in the incidences of neurovascular diseases among the geriatric population, and increased demand for minimally invasive surgical interventions for neurosurgery procedures are anticipated to fuel the market growth in the Asian Pacific region.

Interventional Neurology Market Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Application launches have accelerated the growth of the Sample Preparation market. Key players in the market include-

• Abbott Laboratories
• Johnson & Johnson
• Boston Scientific Corporation
• Stryker Corporation
• Medtronic PLC
• Terumo Corporation
• Penumbra Inc.
• Microport Scientific Corporation
• Merit Medical Systems Inc.
• L. Gore & Associates Inc.
• Braun

Recent Development

• In February 2022, the U.S. based medical device firm named InspireMD, Inc. received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) supplement application and Carotid Revascularization Endarterectomy or Stenting Trial (CREST-2).
• In March 2021, the firm named Innovative Cardiovascular Solutions (ICS) stated the positive results from European clinical cases which uses the next-generation version of the Embolic Protection System (EMBLOK) in patients undergoing the transcatheter aortic valve replacement (TAVR).
• In December 2020, the Japan-based firm named Terumo Corporation announced the launch of an intrasaccular aneurysm treatment device called the WEB embolization system for an enhanced approach to complex stenting procedures.

Table of Content

1. Introduction
   • Market Introduction
   • Market Research Methodology
     • Research Process
     • Primary Research
     • Secondary Research
     • Data Collection Technique
     • Data Sources
   • Market Estimation Methodology
     • Limitations of the Study
   • Product Picture of Interventional Neurology
   • Global Interventional Neurology Market: Classification
   • Geographic Scope
   • Years Considered for the Study
   • Research Methodology in brief
   • Parent Market Overview
   • Overall Interventional Neurology Market Regional Demand
   • Research Programs/Design
   • Market Breakdown and Data Triangulation Approach
   • Data Source
   • Secondary Sources
   • Primary Sources
   • Primary Interviews
   • Average primary breakdown ratio
2. Market Dynamics
   • Drivers
     • Drivers
   • Restraints
     • Restraints
   • Opportunity
     • Impact forces on market dynamics
     • Impact forces during the forecast years
   • Industry Value Chain
     • Upstream analysis
     • Downstream analysis
     • Distribution Channel
     • Direct Channel
     • Indirect Channel
   • Potential Customers
   • Manufacturing/Operational Cost Analysis
   • Pricing Analysis by Region
   • Key Technology Landscape
   • Regulatory Analysis
   • Porter’s Analysis
     • Supplier Power
     • Buyer Power
     • Substitution Threat
     • Threat from New Entry
     • Competitive Rivalry
   • PESTEL Analysis
   • Political Factors
   • Economic Factor
   • Social Factors
   • Technological Factor
   • Environmental Factors
   • Legal Factor
   • Covid-19 impact on Global Economy
   • Covid-19 impact on Interventional Neurology demand
   • Post-Covid Impact on Interventional Neurology Market Demand
   • Impact Analysis of the Russia-Ukraine Conflict
3. Global Interventional Neurology Market Segmentation, by Revenue (USD Billion), (2022-2030)
   • By Product Type
     • Aneurysm Coiling Devices and Cerebral Embolization
       • Embolic coils
       • Flow diversion devices
       • Liquid embolic agents
     • Neurothrombectomy Devices
     • Cerebral Angioplasty and Stenting Systems
     • Support devices
   • By Disease Pathology
     • Arteriovenous Malformation and Fistulas
     • Cerebral Aneurysms
     • Ischemic Strokes
     • Others
       • Cavernous malformations
       • Moyamoya disease
     • By Technique
       • Neurothrombectomy Procedure
       • Cerebral Angiography Technique
       • Carotid Endarterectomy (CEA)
       • Stenting
       • Microsurgical Clipping
       • Coiling
       • Flow Diversion
       • Others
     • By End-Use
       • Hospitals & Surgical Centers
       • Ambulatory Care Centers
       • Research Laboratories & Academic Institutes

4. Global Interventional Neurology Market Overview, By Region
   • North America Interventional Neurology Market Revenue (USD Billion), by Countries, (2022-2030)
     • US
       • By Product Type
       • By Disease Pathology
       • By Technique
       • By End Use
     • Canada
     • Mexico
   • Europe Interventional Neurology Market Revenue (USD Billion), by Countries, (2022-2030)
     • France
     • UK
     • Spain
     • Russia
     • Italy
     • BENELUX
   • Asia Pacific Interventional Neurology Market Revenue (USD Billion), by Countries, (2022-2030)
     • China
     • Japan
     • Australia
     • South Korea
     • India
     • ASEAN

5. Latin America Interventional Neurology Market Revenue (USD Billion), by Countries, (2022-2030)
   • Brazil
   • Argentina
   • Chile
6. Middle East and Africa Interventional Neurology Market Revenue (USD Billion), by Countries, (2022-2030)
   • GCC
   • Turkey
   • South Africa
7. Global Interventional Neurology Market Revenue: Competitive Analysis, 2021
   • Key strategies by players
   • Revenue (USD Billion and %), By manufacturers, 2021
   • Player Positioning by Market Players, 2021
8. Competitive Analysis
   • Abbott Laboratories
     • Business Overview
     • Business Financials (USD Billion)
     • Product Category, Type, and Specification
     • Main Business/Business Overview
     • Geographical Analysis
     • Recent Development
     • Swot Analysis
   • Johnson & Johnson
   • Boston Scientific Corporation
   • Stryker Corporation
   • Medtronic PLC
   • Terumo Corporation
   • Penumbra Inc.
   • Microport Scientific Corporation
   • Merit Medical Systems Inc.
   • L. Gore & Associates Inc.
   • Braun
9. Market Research Findings & Conclusion

Disclaimer

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.